Downstaging hepatocellular carcinoma: A systematic review and pooled analysis

Neehar D. Parikh, Akbar K. Waljee, Amit G. Singal – 15 May 2015 – Downstaging can facilitate liver transplantation (LT) for patients outside of Milan criteria with hepatocellular carcinoma (HCC); however, the optimal protocol and downstaging outcomes are poorly defined. We aimed to characterize rates of successful downstaging to within Milan criteria and post‐LT recurrence and survival among patients who underwent downstaging.

Living donor liver transplantation for Echinococcus Alveolaris: single‐center experience

Fatih Ozdemir, Volkan Ince, Bora Barut, Asim Onur, Cuneyt Kayaalp, Sezai Yilmaz – 15 May 2015 – Echinococcus alveolaris (EA) causes a hepatic zoonotic infection and behaves like a malignant tumor during invasion. Liver transplantation (LT) is the only curative treatment option for this unresectable disease. Here, we share our experience with living donor liver transplantation (LDLT) due to EA from the time between March 2002 and November 2014 at the Liver Transplantation Institute of İnönü University.

Acute kidney injury after orthotopic liver transplantation using living donor versus deceased donor grafts: A propensity score–matched analysis

Ibtesam A. Hilmi, Daniela Damian, Ali Al‐Khafaji, Tetsuro Sakai, Joseph Donaldson, Daniel G. Winger, John A. Kellum – 15 May 2015 – Acute kidney injury (AKI) is a common complication after liver transplantation (LT). Few studies investigating the incidence and risk factors for AKI after living donor liver transplantation (LDLT) have been published. LDLT recipients have a lower risk for post‐LT AKI than deceased donor liver transplantation (DDLT) recipients because of higher quality liver grafts.

Subscribe to